PEN

Penumbra
NYSE

Real-time Quotes | Nasdaq Last Sale

155.37
-3.71
-2.33%
After Hours: 155.82 +0.45 +0.29% 16:11 03/27 EDT
OPEN
154.50
PREV CLOSE
159.08
HIGH
158.70
LOW
151.82
VOLUME
293.59K
TURNOVER
--
52 WEEK HIGH
194.93
52 WEEK LOW
121.80
MARKET CAP
5.45B
P/E (TTM)
116.23
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of PEN and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 6 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average PEN stock price target is 189.20 with a high estimate of 200.00 and a low estimate of 180.00.

EPS

PEN News

More
  • Hedge Funds Have Never Been This Bullish On Penumbra Inc (PEN)
  • Insider Monkey · 1d ago
  • Edited Transcript of PEN earnings conference call or presentation 25-Feb-20 10:00pm GMT
  • Thomson Reuters StreetEvents · 3d ago
  • With EPS Growth And More, Penumbra (NYSE:PEN) Is Interesting
  • Simply Wall St. · 03/19 14:39
  • Here is Why Growth Investors Should Buy Penumbra (PEN) Now
  • Zacks · 03/16 17:45

Industry

Medical Equipment, Supplies & Distribution
-1.60%
Healthcare Equipment & Supplies
-1.86%

Hot Stocks

Symbol
Price
%Change

About PEN

Penumbra, Inc. is a healthcare company focused on interventional therapies. The Company designs, develops, manufactures and markets medical devices. It has a portfolio of products that addresses medical conditions and clinical needs across two markets, neuro and peripheral vascular. The conditions that its products address include ischemic stroke, hemorrhagic stroke and various peripheral vascular conditions that can be treated through thrombectomy and embolization procedures. It focuses on developing, manufacturing and marketing products for use by specialist physicians, including interventional neuroradiologists, neurosurgeons, interventional neurologists, interventional radiologists and vascular surgeons. Its neuro products include Neurovascular Access, Neuro Thrombectomy (Ischemic Stroke), Neurovascular Embolization (Brain Aneurysms) and Neurosurgical Tools (Hemorrhagic Stroke). Its peripheral vascular products include Peripheral Vascular Embolization and Peripheral Thrombectomy.
More

Webull offers kinds of Penumbra Inc stock information, including NYSE:PEN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PEN stock news, and many more online research tools to help you make informed decisions.